BECN1 and serum lipopolysaccharide activity: In a mouse model of endotoxemia, we obtained new findings showing that septic challenge by LPS incites losses in myocardial MAMs, and this damage was alleviated by the targeted activation of Beclin‐1 either genetically or pharmacologically.